The ubiquitous presence of the pharmaceutical industry in doctor education in recent years has tainted medical education. Drug company participation is often part of a companyâ??s marketing plan; the presentations are designed to gin up interest in a new drug or to promote new uses for an old one. Such presentations may lead to overprescribing and quite possibly increases the cost of health care.
Office of Strategic Communication